Status:
COMPLETED
Risk Factors for Carbapenem-resistant Acinetobacter Baumannii
Lead Sponsor:
University of Pittsburgh
Conditions:
Acinetobacter Infections
Eligibility:
All Genders
18+ years
Brief Summary
It has been demonstrated that panresistant strains of Acinetobacter species may be selected by antibiotic use \[4\], may be transmitted from person to person \[5\], and may be passed via environmental...
Detailed Description
The elucidation of potential risk factors for resistant strains of Acinetobacter is therefore an important task, and the use of alternative antibiotics should be considered in ICUs where these strains...
Eligibility Criteria
Inclusion
- Positive cultures of carbapenem-resistant acinetobacter baumannii
Exclusion
- Not meeting inclusion criteria
Key Trial Info
Start Date :
April 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00462579
Start Date
April 1 2007
End Date
June 1 2017
Last Update
June 12 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC
Pittsburgh, Pennsylvania, United States, 15213